Healthcare solution developer Geneia has entered a strategic partnership with Covidien to break into the remote patient monitoring market.
Covidien will provide Geneia the rights to sell its ZephyrLIFE remote patient monitoring solutions in designated markets to power Geneia's @home remote patient monitoring solution.
"As a result of this partnership, we're marrying Geneia's clinical care expertise with Covidien's innovative ZephyrLIFE technology to help improve the quality and cost of care for chronically ill patients in the home setting," said Geneia president and COO Heather Lavoie in a news release.
More articles on supply chain:
5 principles to build a strategic supply chain
Premier to acquire Aperek for $48.5M
GHX secures $5B in supply savings over past 5 years